giacomelli_eli Profile Banner
Elisa Giacomelli Profile
Elisa Giacomelli

@giacomelli_eli

Followers
169
Following
103
Media
0
Statuses
122

Clinical trial innovations at Mass General Hospital & Harvard Medical School | Scientific Communications | External Affairs

Boston, USA
Joined May 2011
Don't wanna be here? Send us removal request.
@studerl
Lorenz
3 years
In vivo gut motility controlled by grafted human PSC-derived ENS in severe mouse model of Hirschsprung’s disease. Study now published @CellStemCell on sacral-derived ENS precursors https://t.co/lyRRzCIvl3. Huge effort by Yujie Fan and an amazing team of collaborators @MSK_CSCB
7
30
102
@BaggioliniA
Arianna Baggiolini
3 years
Happy to welcome @lisapavinato in our lab 🎉🎉🎉 Lisa has won the prestigious EMBO award, which started a collaboration between the Brusco lab in Turin and my lab in Switzerland. Very excited about the work that we will be doing together🤩💪💪💪
2
5
30
@giacomelli_eli
Elisa Giacomelli
3 years
Remarkably, we also show that extrinsic LIF is required as this ligand is normally produced by non-neural cell types such as brain vascular pericytes, and that integrating hPSC-derived cranial pericytes in cortical organoids can substitute for LIF treatment. Check it out 🙌
0
0
3
@giacomelli_eli
Elisa Giacomelli
3 years
This protocol, based on treatment with leukemia inhibitor factor (LIF), dramatically enhances the development of a structured outer subventricular zone germinal layer and outer radial glia progenitor/neural stem cells, two key features of the developing human cortex.
1
0
3
@berteroale
Alessandro Bertero
4 years
First in person seminar after the long haul of the pandemic, and it could not have been a better venue and audience! Thanks Davide Cacchiarelli for the invitation and @Tigem_Telethon for the first in class hospitality
@Tigem_Telethon
Tigem Telethon
4 years
A huge thanks to Alessandro Bertero @berteroale for a great #TigemSeminar yesterday. He discussed new insights on #chromatin organisation from his group, made by studying the differentiation of human pluripotent #stemcells into #cardiomyocytes in disease and normal conditions.
0
1
8
@giacomelli_eli
Elisa Giacomelli
4 years
Don't miss this amazing opportunity in Southern Switzerland! The Baggiolini Lab is opening and looking for PhD students and a Lab technician/Lab assistant!
@BaggioliniA
Arianna Baggiolini
4 years
Come and join us in Switzerland! We are looking for PhD students and a Lab technician/Lab assistant: https://t.co/BvWhyJnfir Application deadline: April 30, 2022 🗓 More info: https://t.co/qMyXkMl6M8 Please RT/share! Yes, we really do have palm trees in Southern Switzerland 😉
0
0
1
@BaggioliniA
Arianna Baggiolini
4 years
The Baggiolini lab is opening its doors in September 2022 at Institute of Oncology Research (IOR @IOR_Bellinzona, affiliated to USI @USI_univeristy and member of Bios+).
17
18
114
@CellRepMed
Cell Reports Medicine
4 years
Now @CellStemCell: Researchers evaluate the modeling of neurodegenerative diseases using #iPSCs. They highlight challenges to exploiting iPSC technology's full potential in neurodegenerative diseases. @giacomelli_eli @BVahsen @studerl https://t.co/6NIQn98dOZ
0
5
19
@BVahsen
Björn Vahsen
4 years
Very happy to share our review on ALS and iPSC models of neurodegeneration in @CellStemCell in collaboration with amazing co-author @giacomelli_eli and other great colleagues from the @studerl lab and the Talbot lab.
0
9
26
@giacomelli_eli
Elisa Giacomelli
4 years
As a result of a beautiful collaboration between the @studerl and the Talbot lab, I am pleased to share our review on ALS and iPSC models of neurodegeneration in @CellStemCell. A very special thank you to @BVahsen for his terrific work as co-author! https://t.co/Mr1XEoaiOU
1
6
32
@CellStemCell
Cell Stem Cell
4 years
Happy New Year! Our January 2022 issue is live! The cover story uses iPS models to uncover non-coding structural variations in human brain evolution. Plus we have a Review on ALS and iPS models of neurodegeneration, gastrointestinal assembloids, and more! https://t.co/aGkqvAoDP3
0
4
12
@giacomelli_eli
Elisa Giacomelli
4 years
Check out this beautiful story from my friend and colleague @BaggioliniA. Terrific collaboration between the @whitefishlab ,@studerl and @sloan_kettering
@BaggioliniA
Arianna Baggiolini
4 years
Oncogenic competence in melanoma. Check out our work today at @ScienceMagazine 👇 This is the fruit of a terrific collaboration between the @whitefishlab & @studerl lab @sloan_kettering
0
0
3
@BaggioliniA
Arianna Baggiolini
4 years
Oncogenic competence in melanoma. Check out our work today at @ScienceMagazine 👇 This is the fruit of a terrific collaboration between the @whitefishlab & @studerl lab @sloan_kettering
@whitefishlab
richard white
4 years
Why do mutations only sometimes cause cancer? In our new @ScienceMagazine paper, we describe a mechanism for this called "oncogenic competence":
12
20
108
@studerl
Lorenz
4 years
For those interested in the topic - Below the accompanying perspective in the same @ScienceMagazine issue by Vredevoogd & Pepper. Enabling oncogenes
Tweet card summary image
science.org
Melanoma can arise only from cells with a permissive chromatin landscape
0
7
19
@giacomelli_eli
Elisa Giacomelli
4 years
Our work on cardiac microtissues and multiwell MEAs to study the electrical phenotype of long QT syndrome is out! Thanks to the amazing team @Luca_Sala, Dorien Ward-van Oostwaard, and @MilenaBellin Check it out! https://t.co/QuPXRriUrS
1
3
5
@BaggioliniA
Arianna Baggiolini
4 years
Thanks to all the amazing collaborators that supported our work: Mathias Treier, @studerl, @KonradBasler, Mitchell Levesque, Reinhard Dummer, @LabSantoro, @ClaudioCantu81. In particular to Mattias Pernebrink from the @ClaudioCantu81 lab
0
3
4
@BaggioliniA
Arianna Baggiolini
4 years
Check out our newest paper on Sall4 and the epigenetic regulation of melanoma cell invasiveness @NatureComms from the Sommer lab @UZH_Science. Major shout out to Johanna Diener.
nature.com
Nature Communications - Melanoma cells can switch between proliferative and invasive phenotypes. Here the authors show that the embryonic stem cell factor Sall4 is a negative regulator of melanoma...
3
14
42